⌕
Pulse Biosciences · PLSE · Nasdaq
Tenet 46 · Mixed
Compare
$44.84−3.28%At closeTenet 46 · Mixed
$44.84−1.52 (−3.28%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Pulse Biosciences (PLSE) Institutional Ownership

13F filers reported holding 4.3% of Pulse Biosciences (PLSE) shares as of Sep 30, 2026, across 74 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
4.3%
Sep 30, 2026
13F filers
74
quarter ended Sep 30, 2026
13F value
$157.9M
3.2M shares
Quarter's fund flow
Mild accumulation
21 new · 3 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (21 new · 25 increased · 16 reduced · 3 closed · 9 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 74 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 1, 2026Teplitsky Liane RaeChief Operating OfficerAcquired · Open-market buy1,001$49.95↗
Aug 31, 2026Teplitsky Liane RaeChief Operating OfficerAcquired · Open-market buy1,024$48.80↗
Aug 28, 2026Teplitsky Liane RaeChief Operating OfficerAcquired · Open-market buy1,034$48.35↗
Aug 26, 2026Teplitsky Liane RaeChief Operating OfficerAcquired · Open-market buy1,036$48.24↗
Aug 8, 2026Teplitsky Liane RaeChief Operating OfficerAcquired · Grant / award200,000Restricted Stock Units—↗
Aug 8, 2026Teplitsky Liane RaeChief Operating OfficerAcquired · Grant / award700,000Stock Option (right to buy)—↗
Jun 11, 2026Zanganeh MakydirectorAcquired · Grant / award30,000Stock Option (right to buy)—↗
Jun 11, 2026Zanganeh MakydirectorAcquired · Grant / award14,504Stock Option (right to buy)—↗
Jun 11, 2026van den Broek RicharddirectorAcquired · Grant / award30,000Stock Option (right to buy)—↗
Jun 11, 2026van den Broek RicharddirectorAcquired · Grant / award8,423Stock Option (right to buy)—↗
Jun 11, 2026DUGGAN ROBERT WdirectorAcquired · Grant / award30,000Stock Option (right to buy)—↗
Jun 11, 2026DUGGAN ROBERT WdirectorAcquired · Grant / award12,495Stock Option (right to buy)—↗
Jun 11, 2026Soni Manmeet SinghdirectorAcquired · Grant / award30,000Stock Option (right to buy)—↗
Jun 11, 2026Sainz MariadirectorAcquired · Grant / award30,000Stock Option (right to buy)—↗
Jun 11, 2026Sainz MariadirectorAcquired · Grant / award3,793Stock Option (right to buy)—↗
May 11, 2026DUGGAN ROBERT WdirectorAcquired · Open-market buy660,233$19.69↗
May 11, 2026LAVIOLETTE PAUL AChief Executive OfficerAcquired · Open-market buy15,000$19.69↗
May 11, 2026LAVIOLETTE PAUL AChief Executive OfficerAcquired · Open-market buy15,000$19.69↗
May 11, 2026DUGGAN ROBERT WdirectorAcquired · Open-market buy660,233$19.69↗
Mar 23, 2026UECKER DARRINChief Technology OfficerAcquired · Grant / award100,000Restricted Stock Units—↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Pulse Biosciences do institutions hold?

13F filers reported holding 4.3% of Pulse Biosciences' shares as of Sep 30, 2026, across 74 filers.

How many 13F filers hold Pulse Biosciences?

Pulse Biosciences was held by 74 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.